Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Moinuddin

Moinuddin

Aligarh Muslim University, India

Title: Glycoxidative modification of proteins in diabetes results in generation of neo-antigenic epitopes

Biography

Biography: Moinuddin

Abstract

Structural rearrangements and condensations of proteins under glycoxidative stress have been implicated in various pathological disorders. Novel immunological epitopes upon glycoxidatively modified proteins have been discovered and multi-specific natural antibodies against them have been identified. In this study, we have probed the glycoxidation of Human Serum Albumin (HSA) and human IgG in diabetes type-2. Glycoxidation was found to perturb the structural integrity of HSA and IgG. It affected their aromatic micro-environment and caused the generation of Advanced Glycation End products (AGEs) and aggregate adducts. Generation of N-epsilon-Carboxy Methyl Lysine (CML) was observed under HPLC and LCMS studies. The modified proteins showed altered secondary and tertiary structure that would also affect their function. Glycoxidation caused disordered or amorphous type aggregation in the modified proteins, as confirmed by electron microscopy. It enhanced carbonyl content and reduced the free lysine and arginine content. Modified HSA and IgG presented novel antigenic determinants that lead to an aggressive immune response in the immunized rabbits as was evaluated by ELISA studies. The antibodies had high affinity towards the immunogens. Auto-antibodies derived from T2DM patients exhibited strong affinity towards the modified HSA and IgG in comparison to the respective unmodified proteins. Specificity of serum antibodies from T2DM patients was further confirmed by competitive-inhibition ELISA and gel retardation assays. The study shows that the neo-antigenic determinants on glycoxidatively modified proteins generate specific immune response in diabetes type-2, which may possibly lead to the biomarker development for the disease.